Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17114 | 617 | 38.3 | 75% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
9 | 3 | CHEMISTRY, ORGANIC//JOURNAL OF HETEROCYCLIC CHEMISTRY//KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII | 135847 |
1235 | 2 | INDOLE//BISINDOLYLMETHANES//ELLIPTICINE | 9055 |
17114 | 1 | DUOCARMYCIN//CC 1065//ADOZELESIN | 617 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DUOCARMYCIN | authKW | 2680622 | 11% | 83% | 65 |
2 | CC 1065 | authKW | 1156102 | 5% | 81% | 29 |
3 | ADOZELESIN | authKW | 745241 | 3% | 94% | 16 |
4 | BIZELESIN | authKW | 597399 | 2% | 93% | 13 |
5 | DUOCARMYCIN SA | authKW | 445399 | 1% | 100% | 9 |
6 | KW 2189 | authKW | 346422 | 1% | 100% | 7 |
7 | CARZELESIN | authKW | 254512 | 1% | 86% | 6 |
8 | DUOCARMYCIN A | authKW | 158363 | 1% | 80% | 4 |
9 | AMINOCBI | authKW | 148466 | 0% | 100% | 3 |
10 | CC 1065 ANTITUMOR ANTIBIOTIC | authKW | 148466 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Organic | 4062 | 37% | 0% | 228 |
2 | Chemistry, Medicinal | 3463 | 23% | 0% | 139 |
3 | Chemistry, Multidisciplinary | 792 | 25% | 0% | 154 |
4 | Pharmacology & Pharmacy | 268 | 14% | 0% | 89 |
5 | Oncology | 267 | 13% | 0% | 78 |
6 | Biochemistry & Molecular Biology | 198 | 19% | 0% | 116 |
7 | Toxicology | 53 | 4% | 0% | 22 |
8 | Microbiology | 1 | 2% | 0% | 13 |
9 | Biotechnology & Applied Microbiology | 1 | 2% | 0% | 13 |
10 | Parasitiology | 0 | 0% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DNA INTERACT GRP | 74230 | 0% | 50% | 3 |
2 | CANC DRUG DNA INTERACT GRP | 49489 | 0% | 100% | 1 |
3 | CANC PHARMACOL COMPREHENS CANC | 49489 | 0% | 100% | 1 |
4 | FDN SETAGAYA KU | 49489 | 0% | 100% | 1 |
5 | ITSUU SETAGAYA KU | 49489 | 0% | 100% | 1 |
6 | NEW DRUG OFF | 49489 | 0% | 100% | 1 |
7 | ONCOL MED KLIN | 49489 | 0% | 100% | 1 |
8 | UCLA COMPREHENS CANC | 49489 | 0% | 100% | 1 |
9 | CANC UK DRUG | 49487 | 0% | 50% | 2 |
10 | ORGAN BIOMOL CHEM | 36135 | 5% | 3% | 29 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOORGANIC & MEDICINAL CHEMISTRY | 4115 | 5% | 0% | 33 |
2 | ANTI-CANCER DRUG DESIGN | 2830 | 1% | 1% | 6 |
3 | JOURNAL OF THE AMERICAN CHEMICAL SOCIETY | 2642 | 12% | 0% | 71 |
4 | JOURNAL OF ORGANIC CHEMISTRY | 2567 | 8% | 0% | 52 |
5 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1730 | 5% | 0% | 30 |
6 | JOURNAL OF MEDICINAL CHEMISTRY | 1188 | 4% | 0% | 23 |
7 | HETEROCYCLIC COMMUNICATIONS | 1116 | 1% | 0% | 6 |
8 | JOURNAL OF ANTIBIOTICS | 1052 | 2% | 0% | 12 |
9 | CHEMICAL RESEARCH IN TOXICOLOGY | 936 | 2% | 0% | 10 |
10 | TETRAHEDRON LETTERS | 928 | 6% | 0% | 38 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DUOCARMYCIN | 2680622 | 11% | 83% | 65 | Search DUOCARMYCIN | Search DUOCARMYCIN |
2 | CC 1065 | 1156102 | 5% | 81% | 29 | Search CC+1065 | Search CC+1065 |
3 | ADOZELESIN | 745241 | 3% | 94% | 16 | Search ADOZELESIN | Search ADOZELESIN |
4 | BIZELESIN | 597399 | 2% | 93% | 13 | Search BIZELESIN | Search BIZELESIN |
5 | DUOCARMYCIN SA | 445399 | 1% | 100% | 9 | Search DUOCARMYCIN+SA | Search DUOCARMYCIN+SA |
6 | KW 2189 | 346422 | 1% | 100% | 7 | Search KW+2189 | Search KW+2189 |
7 | CARZELESIN | 254512 | 1% | 86% | 6 | Search CARZELESIN | Search CARZELESIN |
8 | DUOCARMYCIN A | 158363 | 1% | 80% | 4 | Search DUOCARMYCIN+A | Search DUOCARMYCIN+A |
9 | AMINOCBI | 148466 | 0% | 100% | 3 | Search AMINOCBI | Search AMINOCBI |
10 | CC 1065 ANTITUMOR ANTIBIOTIC | 148466 | 0% | 100% | 3 | Search CC+1065+ANTITUMOR+ANTIBIOTIC | Search CC+1065+ANTITUMOR+ANTIBIOTIC |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BOGER, DL , JOHNSON, DS , (1996) CC-1065 AND THE DUOCARMYCINS: UNDERSTANDING THEIR BIOLOGICAL FUNCTION THROUGH MECHANISTIC STUDIES.ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. VOL. 35. ISSUE 13-14. P. 1438 -1474 | 167 | 91% | 224 |
2 | BOGER, DL , BOYCE, CW , GARBACCIO, RM , GOLDBERG, JA , (1997) CC-1065 AND THE DUOCARMYCINS: SYNTHETIC STUDIES.CHEMICAL REVIEWS. VOL. 97. ISSUE 3. P. 787 -828 | 157 | 78% | 193 |
3 | UEMATSU, M , BRODY, DM , BOGER, DL , (2015) A FIVE-MEMBERED LACTONE PRODRUG OF CBI-BASED ANALOGS OF THE DUOCARMYCINS.TETRAHEDRON LETTERS. VOL. 56. ISSUE 23. P. 3101 -3104 | 77 | 95% | 0 |
4 | ROBERTSON, WM , KASTRINSKY, DB , HWANG, I , BOGER, DL , (2010) SYNTHESIS AND EVALUATION OF A SERIES OF C5 '-SUBSTITUTED DUOCARMYCIN SA ANALOGS.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 20. ISSUE 9. P. 2722-2725 | 84 | 94% | 3 |
5 | GHOSH, N , SHELDRAKE, HM , SEARCEY, M , PORS, K , (2009) CHEMICAL AND BIOLOGICAL EXPLORATIONS OF THE FAMILY OF CC-1065 AND THE DUOCARMYCIN NATURAL PRODUCTS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 9. ISSUE 16. P. 1494-1524 | 106 | 73% | 15 |
6 | MACMILLAN, KS , BOGER, DL , (2009) FUNDAMENTAL RELATIONSHIPS BETWEEN STRUCTURE, REACTIVITY, AND BIOLOGICAL ACTIVITY FOR THE DUOCARMYCINS AND CC-1065.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 52. ISSUE 19. P. 5771 -5780 | 77 | 95% | 31 |
7 | CHANDA, PB , BOYLE, KE , BRODY, DA , SHUKLA, V , BOGER, DL , (2016) SYNTHESIS AND EVALUATION OF DUOCARMYCIN SA ANALOGS INCORPORATING THE METHYL 1,2,8,8A-TETRAHYDROCYCLOPROPA[C]IMIDAZOLO[4,5-E]INDOL-4-ONE-6-CARBOXYLATE (CIMI) ALKYLATION SUBUNIT.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 24. ISSUE 20. P. 4779 -4786 | 71 | 95% | 0 |
8 | WOLFE, AL , DUNCAN, KK , PARELKAR, NK , WEIR, SJ , VIELHAUER, GA , BOGER, DL , (2012) A NOVEL, UNUSUALLY EFFICACIOUS DUOCARMYCIN CARBAMATE PRODRUG THAT RELEASES NO RESIDUAL BYPRODUCT.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 55. ISSUE 12. P. 5878 -5886 | 72 | 89% | 19 |
9 | JIN, W , TRZUPEK, JD , RAYL, TJ , BROWARD, MA , VIELHAUER, GA , WEIR, SJ , HWANG, I , BOGER, DL , (2007) A UNIQUE CLASS OF DUOCARMYCIN AND CC-1065 ANALOGUES SUBJECT TO REDUCTIVE ACTIVATION.JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. VOL. 129. ISSUE 49. P. 15391 -15397 | 92 | 80% | 23 |
10 | WOLFE, AL , DUNCAN, KK , PARELKAR, NK , BROWN, D , VIELHAUER, GA , BOGER, DL , (2013) EFFICACIOUS CYCLIC N-ACYL O-AMINO PHENOL DUOCARMYCIN PRODRUGS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 56. ISSUE 10. P. 4104 -4115 | 73 | 87% | 5 |
Classes with closest relation at Level 1 |